Patient death prompts warning for acne treatment minocycline

The TGA has asked GPs to monitor patients prescribed the antibiotic with FBCs

Prescribers have been warned to monitor patients being treated with minocycline after the TGA was alerted to four cases of agranulocytosis including one fatality.


The medicines watchdog says product information for the tetracycline antibiotic is being updated to highlight the rare risk of low granulocyte levels that leaves patients at “very high” risk of serious infection as a result of their suppressed immune system.

GPs are also being asked to monitor patients during treatment with FBCs and LFTs and to keep an eye out for early signs of the